Results 91 to 100 of about 15,430 (233)

Exploring the Vasculitis‐Tumors Link: Epidemiological Patterns, Mechanistic Insights, and Clinical Implications

open access: yesAdvanced Science, Volume 13, Issue 14, 9 March 2026.
This review outlines association between vasculitis and malignancies and provides practical value for clinicians in distinguishing primary vasculitis from malignancy‐associated forms and optimizing patient surveillance, improving recognition of tumor‐associated vasculitis to reduce the risk of misdiagnosis, supporting more accurate clinical decision ...
Xiaofei Shi   +8 more
wiley   +1 more source

Decreasing Serum Adropin Levels in Patients With Systemic Lupus Erythematosus: A Case‐Control Study

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Introduction Systematic lupus erythematosus is a complex fundamental autoimmune disease with relapsing‐remitting course and spectrum of disease ranging from mild to life‐threatening illness. Approximately half of women diagnosed with systemic lupus erythematosus (SLE) are affected by obesity, with rates reaching up to 50%.
Mehrzad Hajialilo   +5 more
wiley   +1 more source

Vision-Threatening Behcet’s Disease: Severity of Ocular Involvement Predictors

open access: yesJournal of Ophthalmology, 2018
Purpose. To examine and spot systemic findings commonly associated with a serious form of ocular Behcet’s disease. This could potentially help ophthalmologists categorize their patients based on future risk and plan treatment accordingly.
Mohammed A. Hussein   +2 more
doaj   +1 more source

2.20 Behcet’s disease and miscellaneous rheumatic conditions [PDF]

open access: yes, 2012
Background: Behcet’s disease is an inflammatory, systemic and chronic disorder with unknown etiology affecting multiple systems of body (1). The cause is not clear but seems to be multifactorial, including immune system dysfunction (humoral and ...
Aflaki, E.   +5 more
core  

Dupilumab Treatment in Pemphigus: A Report of Three Cases and Literature Review

open access: yesJEADV Clinical Practice, Volume 5, Issue 1, Page 254-257, March 2026.
Capsule summary Pemphigus vulgaris and foliaceus are rare autoimmune blistering diseases traditionally treated with corticosteroids, immunosuppressants, intravenous immunoglobulins, and rituximab. A subset of patients remains refractory or has contraindications to these conventional therapies. We present three cases of pemphigus treated with dupilumab.
José Javier Mateos Rico   +5 more
wiley   +1 more source

Tuberculosis Masquerading as Behcet's Disease‐Pseudo Bechet's Syndrome: A Case‐Based Review of Literature

open access: yesRespirology Case Reports
Behcet's disease is a chronic, multisystem variable vessel vasculitis characterised by recurrent oral and genital ulcers, ocular inflammation and a wide range of systemic manifestations.
Rinoosha Rachel   +4 more
doaj   +1 more source

Persistent fever, neck swelling, and small vessel vasculitis following tonsillectomy in a patient with Behçet’s disease: a case report

open access: yesJournal of Medical Case Reports, 2012
Introduction Behçet’s disease commonly presents with recurrent oral and genital mucocutaneous ulcerations, uveitis and various skin manifestations. Other clinical symptoms include gastrointestinal ulcerations, arthritis, venous thrombosis, arterial ...
Wagner Claudia   +3 more
doaj   +1 more source

Thalidomide attenuates multiple low-dose streptozotocin-induced diabetes in mice by inhibition of proinflammatory cytokines [PDF]

open access: yes
Thalidomide is an immunomodulatory and anti-inflammatory agent and is used in autoimmune disorders. It has been shown that thalidomide inhibits proinflammatory cytokines production.
امیرشاهرخی, کیوان   +1 more
core   +1 more source

Genital ulcer severity score and genital health quality of life in Behçet's disease [PDF]

open access: yes, 2015
Background: Behçet's Disease (BD) is a chronic auto-inflammatory, multisystem relapsing/remitting disorder of unknown aetiology. Oro-genital ulceration is a key feature of the disease and has a major impact on the patients' quality of life.
A Fonseca Cardoso   +45 more
core   +3 more sources

Anti-IL1 in patients with low penetrance mutations for autoinflammatory diseases: tuscany and sicilian case series from paediatric to adult age [PDF]

open access: yes, 2017
Patients with low penetrance mutations for Autoinflammatory syndromes (AID) can have severe clinical manifestations, which require to be treated with biological drugs anti-IL-1.
Giovanni Corsello   +4 more
core  

Home - About - Disclaimer - Privacy